Ethical and scientific issues surrounding solid organ transplantation in HIV-positive patients: Absence of evidence is not evidence of absence

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 17, Issue 1, 2006, Pages 15-18

  Christie, Timothy ^a,b,c,f   Jiwani, Bashir ^d,e   Asrat, Getnet ^a,b,c   Montessori, Valentina ^a,b,c   Mathias, Richard ^b   Montaner, Julio ^a,b,c  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Providence Health Care   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e FRASER HEALTH AUTHORITY   (Canada)

^f ST PAUL S HOSPITAL   (Canada)

Author keywords

Ethical decision making; Ethics; Evidence based medicine; Health policy; HIV positive; Liver transplantation

Indexed keywords

ANTIRETROVIRUS AGENT;

CAUSE OF DEATH; EVIDENCE BASED MEDICINE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER GRAFT; LIVER TRANSPLANTATION; MEDICAL ETHICS; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; REVIEW;

EID: 33645693097     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/286301     Document Type: Review

References (22)

1. Wood E, Hogg RS, Harrigan PR, Montaner JS. When to initiate antiretroviral therapy in HIV-1-infected adults: A review for clinicians and patients. Lancet Infec Dis 2005;5:407-14.
2. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-7.
3. Neff G, Jayaweera D, Tzakis A. Liver transplantation for HIV-infected patients with end-stage liver disease. Curr Opin Organ Transplant 2002;7:114-23.
4. Soriano V, Garcia-Samaniego J, Rodriguez-Rosado R, Gonzalez J, Pedreira J. Hepatitis C and HIV infection: Biological, clinical, and therapeutic implications. J Hepatol 1999;31(Suppl 1):119-23.
5. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000;283:74-80.
6. Puoti M, Gargiulo F, Roldan EQ, et al. Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment. J Infect Dis 2000;181:2033-6.
7. Rubin RH, Jenkins RL, Shaw BW Jr, et al. The acquired immunodeficiency syndrome and transplantation. Transplantation 1987;44:1-4.
8. Sayegh SE, Keller MJ, Huprikar S, Murphy B. Solid organ transplantation in HIV-infected recipients. Pediatr Transplant 2004;8:214-21.
9. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001;72:1684-8.
10. Braitstein P. HIV infection and liver transplantation: A review of the literature. BC Medical Journal 2004;46:14-20.
11. Roland M, Carlson L, Ragni M, et al. Solid organ transplantation in HIV-infected recipients: A review of 53 cases in the HAART era. Presented at the International AIDS Conference in Barcelona, Spain, 2002.
12. Ragni MV, Dodson SF, Hunt SC, Bontempo FA, Fung JJ. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood 1999;93:1113-4.
13. Gow PJ, Mutimer D. Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy. AIDS 2001;15:291-2.
14. Sugawara Y, Makuuchi M, Morisawa Y, Kimura S, Tachikawa N, Oka S. [Living donor liver transplantation in a patient with HIV]. Nippon Rinsho 2002;60:803-6.
15. Kuo PC, Stock PG. Transplantation in the HIV+ patient. Am J Transplant 2001;1:13-7.
16. Tolan DJ, Davies MH, Millson CE. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N Engl J Med 2001;345:1781.
17. Ragni MV, Belle SH, Im K, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003;188:1412-20.
18. Stock P, Roland M, Johnson L, et al. Protocol: Clinical, immunologic and pharmacologic consequences of solid organ transplantation in people with HIV infection. Cooperative clinical trials in adult transplantation, University of California, San Francisco, 2002.
19. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003;75:425-9.
20. Moreno S, Fortun J, Quereda C, et al. Liver transplantation in HIV-infected recipients. Liver Transpl 2005;11:76-81.
21. Hartung J, Cottrell JE, Giffin JP. Absence of evidence is not evidence of absence. Anesthesiology 1983;58:298-300.
22. Neff GW, Shire NJ, Rudich SM. Outcomes among patients with end-stage liver disease who are coinfected with HIV and hepatitis C virus. Clin Infect Dis 2005;41(Suppl 1):S50-5.